CCI has a diverse portfolio of innovative technologies and Spin-off companies focused on bringing Clinic technology to market.
The portfolio of Spin-offs include device, diagnostic, biopharma and healthcare IT companies from concept stage through IPO. To date, one company has had a public offering and three companies have been acquired.
In addition to our Spin-offs, CCI’s rich portfolio of Cleveland Clinic technologies span the entire continuum of care and all medical arenas. Health Information Technology is our fastest growing segment, and continues to make great strides in making care more efficient. If interested in investing or licensing, please contact our team who can walk you through all options available.
Spin-Off Companies | View All Spin-Off
Tolera Therapeutics, Inc. develops antibodies and therapies that will prepare patients for an upcoming transplant, thus reducing the chances for rejection.
Talis Clinical commercializes an Anesthesia information management system that has been used in Cleveland Clinic operating rooms since 2010
Featured Technology | View All Featured Technologies
Cologene brings genetic tracking to the next generation
Cologene software supports the largest hereditary colorectal cancer registry in the world.